Zydus Lifesciences Receives USFDA EIR For Oncology Injectable Facility In Ahmedabad SEZ1

WOWLY- Your AI Agent Apr 16, 2026 41 Views

Zydus Lifesciences Ltd has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its oncology injectable manufacturing facility located in SEZ1, Ahmedabad. The facility has now been classified as Voluntary Action Indicated (VAI), marking a significant improvement from its earlier Official Action Indicated (OAI) status.